• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Game Plan For The Next Pharma Leaders

Game Plan For The Next Pharma Leaders

February 21, 2007
CenterWatch Staff

Where should Big Pharma’s next leaders come from?

If you believe that the biotech model is the future of drug development, then executives coming up through the ranks of Big Pharma might be excluded from the top spots. Many experienced pharma execs would be out of the running for CEO. As Big Pharma searches for the way forward, they may seek outsiders such as fumbling Ford did with Alan Mulally from Boeing.

But drug research and development is a difficult business for most non-scientists, and for Big Pharma to get innovative, looking to biotech execs may be the best place to search for their next leaders.

The field is limited, however. There just aren’t that many successful biotech companies. And would a top biotech CEO from a Genentech or a Genzyme even want to leave their successful companies?

And who would want to take on the huge task of transforming pharma?

So the next wave of pharma leaders might have to come from young, up-and-coming leaders at biotechs, such as the heads of research. It is akin to NFL teams raiding the New England Patriots for a 30-something defensive coordinator. Pharma will have to hope that these young biotech leaders can bring their biotech “system” to pharma. It was a risk, but the Jets did it in New York.

So pharma companies may have to look at biotechs’ heads of research or product development and get out the checkbook.

I suppose one way to accomplish this transformation for a pharma company is to buy a big biotech company and set up a clear succession. Or is the solution for a big biotech company to buy a pharma company?

Genentech’s market cap is roughly that of Merck’s. What an integration something like that would be.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing